Cardiol Therapeutics Stock Forward View
| CRDL Stock | USD 0.99 0.03 3.13% |
Cardiol Stock outlook is based on your current time horizon. Although Cardiol Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Cardiol Therapeutics' systematic risk associated with finding meaningful patterns of Cardiol Therapeutics fundamentals over time.
As of now the rsi of Cardiol Therapeutics' share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.11) | EPS Estimate Current Year (0.43) | EPS Estimate Next Year (0.36) | Wall Street Target Price 7.8101 | EPS Estimate Current Quarter (0.10) |
Using Cardiol Therapeutics hype-based prediction, you can estimate the value of Cardiol Therapeutics Class from the perspective of Cardiol Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Cardiol Therapeutics using Cardiol Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Cardiol using crowd psychology based on the activity and movement of Cardiol Therapeutics' stock price.
Cardiol Therapeutics Implied Volatility | 0.86 |
Cardiol Therapeutics' implied volatility exposes the market's sentiment of Cardiol Therapeutics Class stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Cardiol Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Cardiol Therapeutics stock will not fluctuate a lot when Cardiol Therapeutics' options are near their expiration.
The Naive Prediction forecasted value of Cardiol Therapeutics Class on the next trading day is expected to be 0.95 with a mean absolute deviation of 0.03 and the sum of the absolute errors of 1.63. Cardiol Therapeutics after-hype prediction price | USD 0.99 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Cardiol Therapeutics to cross-verify your projections. Open Interest Against 2026-03-20 Cardiol Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Cardiol Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Cardiol Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Cardiol Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Cardiol Therapeutics' open interest, investors have to compare it to Cardiol Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Cardiol Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Cardiol. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Cardiol Therapeutics Additional Predictive Modules
Most predictive techniques to examine Cardiol price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cardiol using various technical indicators. When you analyze Cardiol charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Cardiol Therapeutics Cash Forecast
To forecast cash or other financial indicators, analysts must employ diverse statistical methods, techniques, and algorithms. This approach allows them to detect underlying patterns in the Cardiol Therapeutics' financial statements, predicting their influence on future market prices.
Cash | First Reported 2017-12-31 | Previous Quarter 18.2 M | Current Value 11.6 M | Quarterly Volatility 21.4 M |
Cardiol Therapeutics Naive Prediction Price Forecast For the 9th of February
Given 90 days horizon, the Naive Prediction forecasted value of Cardiol Therapeutics Class on the next trading day is expected to be 0.95 with a mean absolute deviation of 0.03, mean absolute percentage error of 0, and the sum of the absolute errors of 1.63.Please note that although there have been many attempts to predict Cardiol Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Cardiol Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Cardiol Therapeutics Stock Forecast Pattern
| Backtest Cardiol Therapeutics | Cardiol Therapeutics Price Prediction | Research Analysis |
Cardiol Therapeutics Forecasted Value
In the context of forecasting Cardiol Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Cardiol Therapeutics' downside and upside margins for the forecasting period are 0.01 and 4.36, respectively. We have considered Cardiol Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Cardiol Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Cardiol Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 111.3089 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0267 |
| MAPE | Mean absolute percentage error | 0.0266 |
| SAE | Sum of the absolute errors | 1.6261 |
Predictive Modules for Cardiol Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cardiol Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cardiol Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cardiol Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Cardiol Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cardiol Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Cardiol Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Cardiol Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Cardiol Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cardiol Therapeutics' historical news coverage. Cardiol Therapeutics' after-hype downside and upside margins for the prediction period are 0.05 and 4.40, respectively. We have considered Cardiol Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Cardiol Therapeutics is risky at this time. Analysis and calculation of next after-hype price of Cardiol Therapeutics is based on 3 months time horizon.
Cardiol Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Cardiol Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cardiol Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cardiol Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.04 | 3.41 | 0.00 | 0.00 | 6 Events / Month | 7 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.99 | 0.99 | 0.00 |
|
Cardiol Therapeutics Hype Timeline
Cardiol Therapeutics is currently traded for 0.99. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Cardiol is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at -0.04%. %. The volatility of related hype on Cardiol Therapeutics is about 21312.5%, with the expected price after the next announcement by competition of 0.99. About 20.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.3. Cardiol Therapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 6 days. Check out Historical Fundamental Analysis of Cardiol Therapeutics to cross-verify your projections.Cardiol Therapeutics Related Hype Analysis
Having access to credible news sources related to Cardiol Therapeutics' direct competition is more important than ever and may enhance your ability to predict Cardiol Therapeutics' future price movements. Getting to know how Cardiol Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cardiol Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| INCR | INC Research Holdings | (0.02) | 8 per month | 0.00 | (0.21) | 6.06 | (6.21) | 18.96 | |
| CNTB | Connect Biopharma Holdings | (0.01) | 8 per month | 4.33 | 0.11 | 11.89 | (6.63) | 38.27 | |
| VANI | Vivani Medical | (0.07) | 9 per month | 0.00 | (0.09) | 6.99 | (6.76) | 18.98 | |
| MBOT | Microbot Medical | 0.24 | 7 per month | 0.00 | (0.05) | 5.78 | (6.90) | 30.11 | |
| NSPR | InspireMD | 0.06 | 10 per month | 0.00 | (0.09) | 6.53 | (7.11) | 24.29 | |
| ASRT | Assertio Therapeutics | (0.11) | 15 per month | 2.99 | 0.05 | 9.01 | (4.63) | 24.64 | |
| IFRX | InflaRx NV | (0.01) | 6 per month | 0.00 | (0.08) | 7.84 | (9.28) | 43.11 | |
| KLRS | Kalaris Therapeutics | (0.03) | 34 per month | 4.34 | 0.14 | 15.58 | (8.21) | 32.70 | |
| IMA | ImageneBio | (0.24) | 7 per month | 0.00 | (0.09) | 6.76 | (5.18) | 18.29 | |
| HYPR | Hyperfine | 0.03 | 8 per month | 4.27 | 0.00 | 9.09 | (7.22) | 18.91 |
Other Forecasting Options for Cardiol Therapeutics
For every potential investor in Cardiol, whether a beginner or expert, Cardiol Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cardiol Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cardiol. Basic forecasting techniques help filter out the noise by identifying Cardiol Therapeutics' price trends.Cardiol Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cardiol Therapeutics stock to make a market-neutral strategy. Peer analysis of Cardiol Therapeutics could also be used in its relative valuation, which is a method of valuing Cardiol Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Cardiol Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Cardiol Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cardiol Therapeutics shares will generate the highest return on investment. By undertsting and applying Cardiol Therapeutics stock market strength indicators, traders can identify Cardiol Therapeutics Class entry and exit signals to maximize returns.
Cardiol Therapeutics Risk Indicators
The analysis of Cardiol Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cardiol Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cardiol stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.47 | |||
| Standard Deviation | 3.5 | |||
| Variance | 12.23 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Cardiol Therapeutics
The number of cover stories for Cardiol Therapeutics depends on current market conditions and Cardiol Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cardiol Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cardiol Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Cardiol Therapeutics Short Properties
Cardiol Therapeutics' future price predictability will typically decrease when Cardiol Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cardiol Therapeutics Class often depends not only on the future outlook of the potential Cardiol Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cardiol Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 71.6 M | |
| Cash And Short Term Investments | 30.6 M |
Check out Historical Fundamental Analysis of Cardiol Therapeutics to cross-verify your projections. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardiol Therapeutics. Projected growth potential of Cardiol fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Cardiol Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Cardiol Therapeutics requires distinguishing between market price and book value, where the latter reflects Cardiol's accounting equity. The concept of intrinsic value - what Cardiol Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Cardiol Therapeutics' price substantially above or below its fundamental value.
It's important to distinguish between Cardiol Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cardiol Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Cardiol Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.